Clinical Trial Update: Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing intramuscular olanzapine with intramuscular haloperidol in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• intramuscular haloperidol (haloperidol)
• intramuscular olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED